Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Ранг среди акций #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Цена акции
$59.98
Последняя синхронизация: 2024-12-13
Рыночная капитализация
$1.22B
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Longboard Pharmaceuticals, Inc. (LBPH)

Категория

Коэффициент P/B для Longboard Pharmaceuticals, Inc. (LBPH)
Коэффициент P/B на August 2026 TTM: 33.31
Согласно последним финансовым отчетам и цене акций Longboard Pharmaceuticals, Inc., текущий коэффициент P/B (TTM) составляет 33.31. В конце 2022 он составлял 0.91.
История P/B для Longboard Pharmaceuticals, Inc. с 2020 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
2026 (TTM) 33.31 894.31%
2023 3.35 268.15%
2022 0.91 12.83%
2021 0.81 -85.45%
2020 5.54 0.00%
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -80.96%
US
6.2413 -81.26%
NL
2.5054 -92.48%
AU
3.7087 -88.87%
US
- -
CH